Treatment of massive right heart thrombi-in-transit and pulmonary embolism with low-dose ultra-slow tissue plasminogen activator in a patient with severe thrombocytopenia and cardiogenic shock

MeSH terms

• Fibrinolytic Agents / therapeutic use
• Humans
• Pulmonary Embolism* / complications
• Pulmonary Embolism* / drug therapy
• Shock, Cardiogenic / drug therapy
• Shock, Cardiogenic / etiology
• Thrombocytopenia* / drug therapy
• Thrombolytic Therapy
• Thrombosis* / drug therapy
• Tissue Plasminogen Activator